APA

Romero F. A., Vodonick S. M., Criscione K. R., McLeish M. J. & Grunewald G. L. (20040924). Inhibitors of phenylethanolamine N-methyltransferase that are predicted to penetrate the blood-brain barrier: design, synthesis, and evaluation of 3-fluoromethyl-7-(N-substituted aminosulfonyl)-1,2,3,4-tetrahydroisoquinolines that possess low affinity toward the alpha2-adrenoceptor. : Journal of medicinal chemistry.

Chicago

Romero F Anthony, Vodonick Steven M, Criscione Kevin R, McLeish Michael J and Grunewald Gary L. 20040924. Inhibitors of phenylethanolamine N-methyltransferase that are predicted to penetrate the blood-brain barrier: design, synthesis, and evaluation of 3-fluoromethyl-7-(N-substituted aminosulfonyl)-1,2,3,4-tetrahydroisoquinolines that possess low affinity toward the alpha2-adrenoceptor. : Journal of medicinal chemistry.

Harvard

Romero F. A., Vodonick S. M., Criscione K. R., McLeish M. J. and Grunewald G. L. (20040924). Inhibitors of phenylethanolamine N-methyltransferase that are predicted to penetrate the blood-brain barrier: design, synthesis, and evaluation of 3-fluoromethyl-7-(N-substituted aminosulfonyl)-1,2,3,4-tetrahydroisoquinolines that possess low affinity toward the alpha2-adrenoceptor. : Journal of medicinal chemistry.

MLA

Romero F Anthony, Vodonick Steven M, Criscione Kevin R, McLeish Michael J and Grunewald Gary L. Inhibitors of phenylethanolamine N-methyltransferase that are predicted to penetrate the blood-brain barrier: design, synthesis, and evaluation of 3-fluoromethyl-7-(N-substituted aminosulfonyl)-1,2,3,4-tetrahydroisoquinolines that possess low affinity toward the alpha2-adrenoceptor. : Journal of medicinal chemistry. 20040924.